Crinetics Pharmaceuticals (CRNX) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Crinetics Pharmaceuticals (CRNX) over the last 6 years, with Q3 2025 value amounting to -$1.38.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) fell 4375.0% to -$1.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.52, marking a year-over-year decrease of 2183.29%. This contributed to the annual value of -$3.68 for FY2024, which is 22.49% up from last year.
- Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to -$1.38 in Q3 2025, which was down 4375.0% from -$1.23 recorded in Q2 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at -$0.73 during Q3 2021, and registered a low of -$1.38 during Q3 2025.
- In the last 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.93 in 2024 and averaged -$0.93.
- Per our database at Business Quant, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) soared by 495.05% in 2024 and then plummeted by 4375.0% in 2025.
- Over the past 5 years, Crinetics Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.8 in 2021, then fell by 3.55% to -$0.83 in 2022, then decreased by 6.02% to -$0.88 in 2023, then dropped by 13.07% to -$0.99 in 2024, then plummeted by 38.7% to -$1.38 in 2025.
- Its last three reported values are -$1.38 in Q3 2025, -$1.23 for Q2 2025, and -$1.04 during Q1 2025.